Tehran University of Medical Sciences

Science Communicator Platform

Share By
Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment Publisher



Arjmand B1, 2 ; Alavimoghadam S1 ; Khorsand G3 ; Sarvari M4 ; Arjmand R1 ; Rezaeitavirani M5 ; Rajaeinejad M6 ; Mosaed R2, 7
Authors

Source: Regenerative Engineering and Translational Medicine Published:2024


Abstract

Purpose: Cancer is now regarded as one of the significant public health concerns, and it is predicted to overtake cardiovascular diseases in 2060. Accordingly, there is a need for new, powerful medications to decrease the impact of cancer. Herein, metastatic tumors can be prevented or eliminated using preventative and therapeutic cancer vaccinations, especially cell-based types. However, further studies are needed in such a field. Therefore, the authors have reviewed the significance of cancer prevention, treatment, and management measures, particularly the use of cell-based vaccines. Methods: In order to find research on cell-based vaccinations and cancer therapies, we searched the literature using a combination of keywords to obtain publications published in PubMed, Scopus, and Web of Science between the years 2000 and 2023. Relevant and highly referenced articles were selected for this list. Results: In this review, we discuss the different types of cancer vaccines especially cell-based types. Further, we summarize related preclinical and clinical studies and also the ethical considerations. Present studies confirm the beneficial results of cell-based vaccines. Conclusion: Advancements of cancer management and immunotherapy have successfully elicited anti-cancer immune responses using chimeric antigen receptor (CAR)-T cells treatment, natural killer (NK) cell therapy, CAR-NK cell therapy, and cell-based vaccines. Lay Summary: Research has shown that powerful drugs are needed to decrease the consequences of cancer. In recent years, many types of immunotherapy have made considerable advancements in the treatment of cancer. These consist of NK cell treatment, CAR-NK cells, and CAR-T cell therapy. Recently, advancements in cancer vaccines, such as immunizations based on cells, have been made. Spreading cancers can now be totally prevented or halted thanks to prophylactic and cancer-specific vaccines. However, further research is needed to understand and progress in this area of treatment fully. © The Author(s), under exclusive licence to The Regenerative Engineering Society 2024.
3. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
Experts (# of related papers)
Other Related Docs
4. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
6. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
7. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
9. Targeted Cancer Therapy: Review Article, Tehran University Medical Journal (2018)
11. Cancer Immunoprevention: Current Status and Future Directions, Archivum Immunologiae et Therapiae Experimentalis (2021)
14. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
16. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
17. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
18. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
19. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
20. Tumor Immunology, Clinical Immunology (2022)